Institutional investors purchased a net $884.0 thousand shares of ENZ during the quarter ended April 2017, and now own 65.79% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ALLIANZ GLOBAL INVESTORS U.S. LL... Bought 338.2 Thousand shares of Enzo Biochem Inc
BLACKROCK FUND ADVISORS Bought 283.8 Thousand shares of Enzo Biochem Inc
EVERMORE GLOBAL ADVISORS LLC Bought 242.4 Thousand shares of Enzo Biochem Inc